Search

Your search keyword '"Dan, Yock Young"' showing total 231 results

Search Constraints

Start Over You searched for: Author "Dan, Yock Young" Remove constraint Author: "Dan, Yock Young" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
231 results on '"Dan, Yock Young"'

Search Results

1. 919 GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES

2. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH

3. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver

4. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and ‘bad apple’ effect on clinical trajectory

5. Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon

6. Platform for the interdisciplinary study of cardiovascular, metabolic and neurovascular diseases (PICMAN) protocol

8. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

9. Rising global burden of cancer attributable to high BMI from 2010 to 2019

10. Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma

13. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

14. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies

16. Contributors

17. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

18. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

20. THU-200-YI Clearance of senescent cells alleviates metabolic dysfunction-associated steatohepatitis

21. SAT-281 Clinical characteristics, surveillance, treatment allocation and outcomes of alcohol-related hepatocellular carcinoma: meta-analysis of 37 studies and 66, 559 patients

22. WED-238 High pancreatic fat and reduced volume stratify patients with F4 liver fibrosis

23. Single-cell and spatial atlas of steatotic liver-related hepatocellular carcinoma

24. Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis

29. Trajectory of immune evasion and cancer progression in hepatocellular carcinoma

32. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study

33. The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis

35. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer

38. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality

40. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma

41. Rising global burden of cancer attributable to high BMI from 2010 to 2019

43. Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation

45. Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females

46. Performance of non-invasive markers in evaluating presence and severity of liver fibrosis in non-alcoholic fatty liver disease: results from a multi-ethnic Asian cohort of biopsy-proven non-alcoholic fatty liver disease patients

50. Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer.

Catalog

Books, media, physical & digital resources